Pembrolizumab
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pharmacovigilance and Adverse Drug Reactions
Lung Cancer Treatments and Mutations
Publication details
- Journal / source
- Reactions Weekly
- Volume
- 2100
- Issue
- 1
- Pages
- 103–103
- Publication date
- 7 March 2026
- Language
- EN